|
|
|
|
|
|
|
| Security Name: |
BIO TECHNOLOGY GENERAL CO |
| Cusip: |
IBM |
| Realized Gain/Loss: |
N/A |
|
|
| Reference #: |
C123456 |
K12345 |
| Transaction Type: |
TRANSFER IN |
Sale |
| Trade Date: |
N/A |
10/01/1999 |
| Quantity: |
100 |
100 |
| Price: |
$0.00 |
$25.31 |
| Principal: |
$0.00 |
$2,531.25 |
| Commission: |
$0.00 |
$20.00 |
| Interest: |
N/A |
N/A |
| Fees: |
$0.00 |
$0.00 |
| Total Cost/Proceeds: |
$0.00 |
$2,511.16 |
| Amortization: |
N/A |
N/A |
|
|
First Republic Securities is not authorized to give tax advice. The information displayed should be considered general reference. Cost basis information for securities acquired prior to activation of the tax lot accounting system or for securities delivered into your account after purchase, has been provided to First Republic Securities by you. First Republic Securities makes no representation as to the accuracy of information provided by clients. Total realized and unrealized gains and losses do not include securities for which no cost basis is available. Note: In the absence of instruction to the contrary, sell transactions will be recorded on a first in first out (FIFO) accounting basis. Cost basis may change in the event of the death of an account owner. Consult your attorney or tax advisor for additional information.
|
|
|
|
|
|
| Investments in Stocks, Mutual Funds and Options are: |
| Not FDIC Insured, Not Bank Guaranteed, May Lose Value |
|
|
|
